Timothy C. Stonesifer has bought stock on 2 days since Dec 2025
Director at Insulet Corporation, and 1 other company
SEC CIK 0001656085 · Filings on SEC.gov ↗
Timothy C. Stonesifer's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
7 filings since Sep 2016, newest first
INSULET CORP
Director
Insulet Corp
Director
Hewlett Packard Enterprise Co
EVP and CFO
Hewlett Packard Enterprise Co
EVP and CFO
Hewlett Packard Enterprise Co
EVP and CFO
Hewlett Packard Enterprise Co
EVP and CFO
Hewlett Packard Enterprise Co
EVP and CFO
About Timothy C. Stonesifer
Timothy C. Stonesifer is a corporate finance executive and individual insider who serves as a Director of Insulet Corporation (NASDAQ: PODD) and as Senior Vice President and Chief Financial Officer of Alcon Inc.( Insulet appointed Stonesifer to its board of directors effective January 2024, where he contributes more than three decades of global financial and operational experience to the medical device maker’s governance and strategy.( As an Insulet director, he has reported insider stock acquisitions, including a June 3, 2026 purchase of common stock valued at approximately $400,392.(
Stonesifer has been Alcon’s CFO since 2019, overseeing the eye-care company’s global finance organization following its spinoff from Novartis.( Previously, he served as Executive Vice President and Chief Financial Officer at Hewlett Packard Enterprise, including prior roles as Senior Vice President and CFO of HP’s Enterprise Group.( His earlier career includes leadership posts as Chief Financial Officer of General Motors’ International Operations, CFO of Algeco Scotsman, CFO of Sabic Innovative Plastics (formerly GE Plastics), and a series of finance positions at General Electric, where he began his career in 1989.( Stonesifer holds a Bachelor of Arts in Economics from the University of Michigan.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.